{"id":"https://openalex.org/W2947435541","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.2517","title":"Prognostic and predictive value of an immune-related adverse event among stage III melanoma patients included in the EORTC 1325/KEYNOTE-054 pembrolizumab versus placebo trial.","display_name":"Prognostic and predictive value of an immune-related adverse event among stage III melanoma patients included in the EORTC 1325/KEYNOTE-054 pembrolizumab versus placebo trial.","publication_year":2019,"publication_date":"2019-05-20","ids":{"openalex":"https://openalex.org/W2947435541","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.2517","mag":"2947435541"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2019.37.15_suppl.2517","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.2517","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.2517","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052579165","display_name":"Alexander M.M. Eggermont","orcid":"https://orcid.org/0000-0002-4278-040X","observed_orcids":["https://orcid.org/0000-0002-4278-040X","https://orcid.org/0000-0001-7458-4326"]},"institutions":[{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Alexander M. M. Eggermont","raw_affiliation_strings":["Gustave Roussy Cancer Centre and University Paris-Saclay, Paris, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gustave Roussy Cancer Centre and University Paris-Saclay, Paris, France;","institution_ids":["https://openalex.org/I277688954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033330872","display_name":"Michal Kici\u0144ski","orcid":"https://orcid.org/0000-0002-7066-0587","observed_orcids":["https://orcid.org/0000-0002-7066-0587"]},"institutions":[{"id":"https://openalex.org/I4210124801","display_name":"European Organisation for Research and Treatment of Cancer","ror":"https://ror.org/034wxcc35","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I4210124801"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Michal Kicinski","raw_affiliation_strings":["EORTC Headquarters, Brussels, Belgium;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EORTC Headquarters, Brussels, Belgium;","institution_ids":["https://openalex.org/I4210124801"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088390068","display_name":"Christian U. Blank","orcid":"https://orcid.org/0000-0002-7945-5846","observed_orcids":["https://orcid.org/0000-0002-7945-5846"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Christian U. Blank","raw_affiliation_strings":["Netherlands Cancer Institute, Amsterdam, Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Netherlands Cancer Institute, Amsterdam, Netherlands;","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010492722","display_name":"Mario Mandal\u00e0","orcid":"https://orcid.org/0000-0001-8846-8959","observed_orcids":["https://orcid.org/0000-0001-8846-8959"]},"institutions":[{"id":"https://openalex.org/I4210106645","display_name":"Ospedale Papa Giovanni XXIII","ror":"https://ror.org/01savtv33","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210106645"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mario Mandal\u00e0","raw_affiliation_strings":["Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy;","institution_ids":["https://openalex.org/I4210106645"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070576000","display_name":"Georgina Venetia Long","orcid":"https://orcid.org/0000-0001-8894-3545","observed_orcids":["https://orcid.org/0000-0001-8894-3545"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Georgina V. Long","raw_affiliation_strings":["Melanoma Institute Australia, The University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melanoma Institute Australia, The University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, Australia;","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I4210118383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110537497","display_name":"Victoria G. Atkinson","orcid":"https://orcid.org/0000-0002-9806-9019","observed_orcids":["https://orcid.org/0000-0002-9806-9019"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Victoria Atkinson","raw_affiliation_strings":["University of Queensland, Brisbane, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Queensland, Brisbane, Australia;","institution_ids":["https://openalex.org/I165143802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073133195","display_name":"St\u00e9phane Dalle","orcid":"https://orcid.org/0000-0002-3423-4548","observed_orcids":["https://orcid.org/0000-0002-3423-4548"]},"institutions":[{"id":"https://openalex.org/I4210100596","display_name":"Hospices Civils de Lyon","ror":"https://ror.org/01502ca60","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"St\u00e9phane Dalle","raw_affiliation_strings":["Hospices Civils de Lyon, Pierre-B\u00e9nite, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospices Civils de Lyon, Pierre-B\u00e9nite, France;","institution_ids":["https://openalex.org/I4210100596"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090545021","display_name":"Andrew Mark Haydon","orcid":"https://orcid.org/0000-0002-4631-5855","observed_orcids":["https://orcid.org/0000-0002-4631-5855"]},"institutions":[{"id":"https://openalex.org/I2801993434","display_name":"The Alfred Hospital","ror":"https://ror.org/01wddqe20","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2801993434","https://openalex.org/I4210163178"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew Mark Haydon","raw_affiliation_strings":["The Alfred Hospital, Melbourne, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Alfred Hospital, Melbourne, Australia;","institution_ids":["https://openalex.org/I2801993434"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112444461","display_name":"Mikhail Lichinitser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090957","display_name":"Russian Cancer Research Center NN Blokhin","ror":"https://ror.org/00ab9fg88","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210090957"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Mikhail Lichinitser","raw_affiliation_strings":["N.N. Blokhin Russian Oncological Scientific Center, Russian Academy of Medical Sciences, Moscow, Russian Federation;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"N.N. Blokhin Russian Oncological Scientific Center, Russian Academy of Medical Sciences, Moscow, Russian Federation;","institution_ids":["https://openalex.org/I4210090957"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108710409","display_name":"Muhammad Adnan Khattak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]},{"id":"https://openalex.org/I2800728469","display_name":"Fiona Stanley Hospital","ror":"https://ror.org/027p0bm56","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799506148","https://openalex.org/I2800728469","https://openalex.org/I2800882159","https://openalex.org/I4388446375","https://openalex.org/I4388482742"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Muhammad Khattak","raw_affiliation_strings":["Fiona Stanley Hospital/University of Western Australia, Perth, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fiona Stanley Hospital/University of Western Australia, Perth, Australia;","institution_ids":["https://openalex.org/I177877127","https://openalex.org/I2800728469"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083061830","display_name":"Matteo Salvatore Carlino","orcid":"https://orcid.org/0000-0002-7861-4104","observed_orcids":["https://orcid.org/0000-0002-7861-4104"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Matteo S. Carlino","raw_affiliation_strings":["Westmead and Blacktown Hospitals, Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Westmead and Blacktown Hospitals, Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia;","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I4210118383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064026461","display_name":"Shahneen Kaur Sandhu","orcid":"https://orcid.org/0000-0002-8660-4475","observed_orcids":["https://orcid.org/0000-0002-8660-4475"]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Shahneen Kaur Sandhu","raw_affiliation_strings":["Peter MacCallum Cancer Centre, The University of Melbourne, Melbourne, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peter MacCallum Cancer Centre, The University of Melbourne, Melbourne, Australia;","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079760997","display_name":"Susana Puig","orcid":"https://orcid.org/0000-0003-1337-9745","observed_orcids":["https://orcid.org/0000-0003-1337-9745"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Susana Puig","raw_affiliation_strings":["Hospital Clinic de Barcelona, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Clinic de Barcelona, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210115097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029398339","display_name":"Paolo A. Ascierto","orcid":"https://orcid.org/0000-0002-8322-475X","observed_orcids":["https://orcid.org/0000-0002-8322-475X"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Paolo Antonio Ascierto","raw_affiliation_strings":["Istituto Nazionale dei Tumori IRCCS Fondazione, Naples, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale dei Tumori IRCCS Fondazione, Naples, Italy;","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037620517","display_name":"Clemens Krepler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Clemens Krepler","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ;","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037357027","display_name":"Nageatte Ibrahim","orcid":"https://orcid.org/0000-0003-0794-949X","observed_orcids":["https://orcid.org/0000-0003-0794-949X"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nageatte Ibrahim","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ;","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061157288","display_name":"Sandrine I. Marreaud","orcid":"https://orcid.org/0000-0002-3205-3858","observed_orcids":["https://orcid.org/0000-0002-3205-3858"]},"institutions":[{"id":"https://openalex.org/I4210124801","display_name":"European Organisation for Research and Treatment of Cancer","ror":"https://ror.org/034wxcc35","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I4210124801"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Sandrine Marreaud","raw_affiliation_strings":["EORTC Headquarters, Brussels, Belgium;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EORTC Headquarters, Brussels, Belgium;","institution_ids":["https://openalex.org/I4210124801"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075441317","display_name":"Alexander C. J. van Akkooi","orcid":"https://orcid.org/0000-0002-3262-6935","observed_orcids":["https://orcid.org/0000-0002-3262-6935"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Alexander Christopher Jonathan Van Akkooi","raw_affiliation_strings":["Netherlands Cancer Institute, Amsterdam, Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Netherlands Cancer Institute, Amsterdam, Netherlands;","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100713900","display_name":"Caroline Robert","orcid":"https://orcid.org/0000-0002-9493-0238","observed_orcids":["https://orcid.org/0000-0002-9493-0238"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Caroline Robert","raw_affiliation_strings":["Paris-Sud University, Gustave Roussy, Villejuif Cedex, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paris-Sud University, Gustave Roussy, Villejuif Cedex, France;","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079852624","display_name":"Stefan Suciu","orcid":"https://orcid.org/0000-0003-3281-8256","observed_orcids":["https://orcid.org/0000-0003-3281-8256"]},"institutions":[{"id":"https://openalex.org/I4210124801","display_name":"European Organisation for Research and Treatment of Cancer","ror":"https://ror.org/034wxcc35","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I4210124801"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Stefan Suciu","raw_affiliation_strings":["EORTC Headquarters, Brussels, Belgium;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EORTC Headquarters, Brussels, Belgium;","institution_ids":["https://openalex.org/I4210124801"]}]}],"institutions":[],"countries_distinct_count":8,"institutions_distinct_count":18,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"15_suppl","first_page":"2517","last_page":"2517"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9929999709129333},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.8799999952316284},{"id":"https://openalex.org/keywords/stage-iii-melanoma","display_name":"stage III melanoma","score":0.9300000071525574},{"id":"https://openalex.org/keywords/recurrence-free-survival","display_name":"recurrence-free survival","score":0.8560000061988831},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6819999814033508},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6269999742507935},{"id":"https://openalex.org/keywords/lymph-node-metastasis","display_name":"lymph node metastasis","score":0.7829999923706055},{"id":"https://openalex.org/keywords/prognostic-value","display_name":"prognostic value","score":0.5139999985694885},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.41499999165534973},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.492000013589859},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.3179999887943268},{"id":"https://openalex.org/keywords/time-to-treatment-failure","display_name":"time to treatment failure","score":0.33000001311302185}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9580341577529907},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.9412431716918945},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7118481397628784},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6546661853790283},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.627142071723938},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.5125460624694824},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5095401406288147},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5062664747238159},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.47423312067985535},{"id":"https://openalex.org/C2780849966","wikidata":"https://www.wikidata.org/wiki/Q170758","display_name":"Lymph node","level":2,"score":0.46498721837997437},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4562346935272217},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3904077708721161},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3141253590583801},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.10933816432952881},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2019.37.15_suppl.2517","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.2517","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.2517","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2997720498","https://openalex.org/W2981048859","https://openalex.org/W3046871465","https://openalex.org/W3029267164","https://openalex.org/W2890208257","https://openalex.org/W3206209054","https://openalex.org/W4416075622","https://openalex.org/W4295817060","https://openalex.org/W6902110957","https://openalex.org/W4200557166"],"abstract_inverted_index":{"2517":[0],"Background:":[1],"Several":[2],"studies":[3],"suggested":[4],"that":[5,62,110],"patients":[6],"(pts)":[7],"with":[8,78,105,129,159,244,353,360,364],"an":[9,40,239,311,314,324,348],"immune-related":[10],"adverse":[11],"event":[12],"(irAE)":[13],"during":[14],"immunotherapy":[15],"have":[16],"better":[17],"outcomes":[18],"than":[19,181,322],"those":[20,358],"without.":[21],"It":[22],"remains":[23],"uncertain":[24],"whether":[25],"these":[26],"observations":[27],"can":[28],"be":[29],"explained":[30],"by":[31],"guarantee-time":[32],"bias":[33],"or":[34,99,299],"the":[35,48,57,138,148,151,160,164,179,183,196,210,218,249,271,289,292,295,302,334,345],"role":[36],"of":[37,42,81,153,203,238,297,313,347],"irAE":[38,139,204,240,315,325,349],"as":[39,89],"indicator":[41],"drug":[43],"activity.":[44],"Here,":[45],"we":[46],"investigated":[47],"association":[49,149,275],"between":[50,150],"irAEs":[51,154],"and":[52,65,104,127,141,155,215,234,267],"recurrence-free":[53],"survival":[54],"(RFS)":[55],"in":[56,67,114,163,178,182,209,217,225,232,248,270,294,301,339,357],"double-blind":[58],"EORTC":[59,335],"1325/KEYNOTE-054":[60,336],"trial":[61,367],"compared":[63],"pembrolizumab":[64,180,211,250,303],"placebo":[66,184,219,272,290],"high-risk":[68,340],"stage":[69,90,128,341],"III":[70,342],"melanoma":[71,83,343],"pts.":[72],"Methods:":[73],"Eligible":[74],"pts":[75,193],"included":[76],"adults":[77],"complete":[79],"resection":[80],"cutaneous":[82],"metastatic":[84],"to":[85,146,288],"lymph":[86],"node(s),":[87],"classified":[88],"IIIA":[91],"(lymph":[92],"node":[93],"metastasis":[94],">":[95],"1":[96],"mm),":[97],"IIIB":[98],"IIIC":[100],"(without":[101],"in-transit":[102],"metastasis)":[103],"no":[106,274],"active":[107],"autoimmune":[108],"disease":[109],"required":[111],"systemic":[112],"treatment":[113,197,227],"past":[115],"2":[116],"years.":[117],"We":[118],"used":[119],"a":[120,130,134,142,245,354],"Cox":[121],"model":[122],"adjusted":[123],"for":[124,264],"sex,":[125],"age,":[126],"time-varying":[131],"covariate":[132],"taking":[133],"value":[135,143],"zero":[136],"before":[137],"onset":[140,312],"one":[144],"afterwards":[145],"estimate":[147],"occurrence":[152,237,346],"RFS.":[156],"Results:":[157],"Consistent":[158],"main":[161],"analysis":[162],"ITT":[165],"population":[166],"(n":[167,198,212,221],"=":[168,187,199,213,222,253,259,279,285,308,317,327],"1019,":[169],"Eggermont":[170],"et":[171],"al,":[172],"NEJM,":[173],"2018),":[174],"RFS":[175,247,356],"was":[176,207,230,241,262,276,305,350],"longer":[177,246,355],"arm":[185,220,251,304],"(HR":[186,252,278,316,326],"0.56,":[188],"98.4%":[189],"CI:":[190,256,282,320,330],"0.43-074)":[191],"among":[192],"who":[194],"started":[195],"1011).":[200],"The":[201,236],"incidence":[202],"on":[205],"study":[206,337],"37.3%":[208],"509)":[214],"9.0%":[216],"502)":[223],"and,":[224],"each":[226],"group,":[228],"it":[229],"similar":[231],"males":[233,266],"females.":[235,268],"significantly":[242],"associated":[243,352],"0.61,":[254,328],"95%":[255,281,319,329],"0.39-0.95,":[257],"P":[258,284],"0.03).":[260],"This":[261],"true":[263],"both":[265],"However,":[269],"arm,":[273,291],"observed":[277],"1.39,":[280],"0.83-2.32,":[283],"0.21).":[286],"Compared":[287],"reduction":[293],"hazard":[296],"recurrence":[298],"death":[300],"greater":[306],"(P":[307],"0.028)":[309],"after":[310],"0.37,":[318],"0.24-0.57)":[321],"without/before":[323],"0.49-0.77).":[331],"Conclusions:":[332],"In":[333],"conducted":[338],"pts,":[344],"strongly":[351],"treated":[359],"pembrolizumab,":[361],"but":[362],"not":[363],"placebo.":[365],"Clinical":[366],"information:":[368],"NCT02362594.":[369]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":5}],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2019-06-07T00:00:00"}